Higher Co-Payments Discourage Patients With Newly Diagnosed Chronic Illnesses From Starting Drug Treatment
Patients newly diagnosed with hypertension, diabetes or high cholesterol are significantly more likely to delay initiating recommended drug treatment if they face higher co-payments for medications.